Revenue per patient in Q3FY20 is Rs 923 as compared to Rs 898 in Q3FY19, an increase of 2.7 per cent YoY
Metropolis Healthcare recently announced its un-audited consolidated financial results for the quarter ended December 31, 2019.
Key Highlights Q3FY20
- Our network as of Q3FY20 consists of 125 laboratories and 2,781 patient service centres
- Revenue per patient in Q3FY20 is Rs 923 as compared to Rs. 898 in Q3FY19, an increase of 2.7 per cent YoY
- A total of 19 new tests (7 in chemistry, 11 in molecular pathology and 1 in infectious molecular) have been validated and added to the test menu in Q3FY20 thus expanding capabilities to conduct more specialised test
- Our upcoming segment wellness has shown strong growth at 60 per cent on YoY basis. This segment now contributes to 7.9 per cent of overall revenues in Q3FY20